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CD45 regulates Src family member kinase activity associated
with macrophage integrin-mediated adhesion
Tamara Roach*, Suzanne Slater*, Michael Koval*, Lynn White†‡, Ellen Cahir
McFarland†‡, Meinoshin Okumura†‡, Matthew Thomas†‡ and Eric Brown*
Background: Adhesion of leukocytes to the extracellular matrix and to other
cells is mediated by members of the integrin family of adhesion molecules. Src
family kinases are activated upon integrin-mediated adhesion. In lymphocytes,
CD45 is a leukocyte-specific transmembrane protein tyrosine phosphatase that
activates Src family kinases associated with B-cell and T-cell antigen receptor
signaling by constitutive dephosphorylation of the inhibitory carboxy-terminal
tyrosine phosphorylation site. Here, we show that CD45 is also important in
downregulating the kinase activity of Src family members during integrin-
mediated adhesion in macrophages.
Results: We found that CD45 colocalized with b2 integrin and the Src family
kinase p53/56lyn to adhesion sites in bone marrow-derived macrophages.
Macrophages from CD45–/– mice were unable to maintain integrin-mediated
adhesion. In adherent macrophages, absence of CD45 led to the
hyperphosphorylation and hyperactivation of p56/59hck and p53/56lyn, but not
of p58c-fgr. CD45 directly inactivated p59hck but not p56lck in transient
transfection assays. Furthermore, coexpression of CD45 with p59hck or p56lyn
containing a tyrosine to phenylalanine mutation at the carboxy-terminal negative
regulatory site resulted in decreased tyrosine phosphorylation of the Src family
member kinases due to dephosphorylation of the potentiating tyrosine
phosphorylation site within the kinase domain. 
Conclusion: Using primary bone marrow macrophages, these studies
demonstrate that CD45 regulates Src family kinases and is required 
to maintain macrophage adhesion. CD45 decreases Src family kinase activity
by dephosphorylating the tyrosine residue located within the kinase 
domain.
Background
Adhesion of leukocytes to the extracellular matrix and to
other cells is mediated by members of the integrin family
of adhesion molecules [1,2]. The activation of tyrosine
kinases, including Src kinase family members, by the
binding of ligands to integrins is necessary for motility and
morphogenesis as well as adhesion-dependent cell growth
and gene induction [3,4]. Protein tyrosine phosphatases
(PTPases) are antagonists to tyrosine kinases and could
thereby serve to regulate the tyrosine phosphorylation
events that are necessary for adhesion and signal transduc-
tion. Indeed, several transmembrane PTPases have
recently been implicated in the regulation of cell–cell and
cell–substrate adhesion [5,6]. It is likely that at least one
role of PTPases in these systems is to regulate the tyrosine
phosphorylation state of other proteins in adhesion com-
plexes [5,7,8]. As tyrosine phosphorylation is an important
component of integrin-mediated adhesion, it is conceiv-
able that a transmembrane PTPase might also function to
regulate this contact.
CD45 is a leukocyte-specific member of the transmem-
brane PTPase family [9]. Analysis of both CD45–/– lym-
phocyte cell lines and CD45–/– mice has demonstrated that
CD45 is essential for efficient T-cell and B-cell antigen
receptor signaling [10,11]. In T-cell antigen receptor-
mediated activation, CD45 dephosphorylates the inhibi-
tory carboxy-terminal tyrosine residue of Src family kinases
p59fyn and p56lck, providing an essential step in the activa-
tion of these kinases [12–14], because antigen-induced
activation is greatly diminished in the absence of CD45.
The function of CD45 in other leukocytes has not been
precisely defined. Studies using antisense oligonucleotides
to CD45 or anti-CD45 monoclonal antibodies have impli-
cated CD45 in the growth of myeloid precursors induced
by granulocyte macrophage colony-stimulating factor
(GM-CSF) and interleukin-3 (IL-3) [15], the phagocyte
respiratory burst [16,17] and neutrophil chemotaxis [18].
Given the ability of CD45 to regulate Src family members
and the importance of the Src kinases in integrin-mediated
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adhesion, we have investigated the role of CD45 in adhe-
sion of murine macrophages. Our studies have revealed
that CD45 functions in primary macrophages to regulate
integrin-mediated adhesion. The absence of CD45 expres-
sion correlates with dysregulation of integrin-mediated
adhesion and an increase in the tyrosine phosphorylation
and activity of the myeloid-specific Src kinases p56/59hck
and p53/56lyn. Thus, the role of CD45 in regulation of
adhesion-dependent Src family kinases is distinct from its
role in antigen receptor activation in lymphocytes. 
Results
CD45 is present at focal contacts
The ubiquitous expression of CD45 on the surface of all
nucleated cells of hematopoietic origin, and the known
function of CD45 in regulating Src kinase activity, sug-
gested that CD45 may have a role in adhesion. To
examine whether CD45 was present at adhesion sites in
macrophages, bone marrow macrophages were induced to
differentiate in vitro from non-adherent precursors using
macrophage colony stimulating factor, M-CSF. Adherent
differentiated macrophages were harvested after 6 days of
M-CSF treatment, and replated on glass coverslips. The
localization of different proteins to adhesion contacts was
determined by confocal microscopy, using the accumula-
tion of tyrosine-phosphorylated proteins and F-actin as
markers for adhesion sites, because these markers have
been used in many other cell types [19]. Phosphotyrosine-
containing proteins, detected by anti-phosphotyrosine
antibody (anti-P-Tyr; green image), and F-actin, detected
by phalloidin (red image), were found to colocalize exten-
sively, as demonstrated by the yellow/orange color on the
combined image of the adherent surface of either CD45+/+
or CD45–/– macrophages (Fig. 1a–f). CD45 and F-actin also
colocalized to focal adhesion sites (Fig. 1g–i). In addition,
CD45 colocalized with phosphotyrosine-containing pro-
teins at adhesion sites (Fig. 1m–o). The b2 integrin CR3,
which enables macrophages to adhere and spread on glass
[20], and the Src family kinase p53/56lyn were also present
at adhesion sites (Fig. 1p–u). Significantly, the major histo-
compatibility complex (MHC) class I glycoprotein did not
Figure 1
Colocalization of CD45, F-actin and phosphotyrosine at sites of
macrophage adhesion. Macrophages from either CD45+/+ or CD45–/–
mice were harvested, replated onto glass coverslips with 5% L-cell
supernatant and allowed to adhere prior to staining. Confocal
fluorescent microscopy (a–f,m–u) or epifluorescent microscopy (g–l)
of 0.5% Triton-extracted cells, focussing on the adherent surface, was
used to determine the colocalization of specific proteins.
Accumulations of F-actin, stained with rhodamine phalloidin (red
images; a,d) and tyrosine phosphorylated proteins (P-Tyr), stained with
anti-P-Tyr and fluorescein-conjugated anti-mouse IgG (green images;
b,e) were observed at focal adhesion sites, membrane ruffles, leading
edges and filopodia in both CD45–/– and CD45+/+ macrophages (a–f).
Combined red and green staining is shown in (c,f) where colocalized
proteins are visible as orange/yellow images. Only CD45+/+ cells are
shown for staining with CD45, MHC class I, CR3 and p53/56lyn (g–u).
Similar results were obtained for localization of CR3 and p53/56lyn in
CD45–/– cells (data not shown). CD45 but not MHC class I (CY3-
coupled anti-rat and anti-mouse secondary antibodies; g,j) colocalized
with F-actin (stained with FITC-phalloidin; h,k) as indicated by yellow
on the combined images (i,l). Staining for CD45, CR3 and p53/56lyn,
using CY3-coupled anti-rat or anti-rabbit secondary antibodies (red
images; m,p,s, respectively), were performed simultaneously with
staining for P-Tyr proteins, (green images; n,q,t respectively).
Colocalizations of CD45, CR3 and p53/56lyn with P-Tyr are shown
(o,r,u, respectively). 
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colocalize with F-actin (Fig. 1j–l). Control samples stained
with secondary antibodies alone were negative, and there
was no evidence of cross channel leakage (data not shown). 
Adhesion abnormalities in CD45–/– macrophages
The presence of CD45 at focal adhesion sites implied that
this phosphatase might regulate some aspect of adhesion.
To determine whether CD45 has a role in adhesion,the
adhesive properties of macrophages from CD45+/+ and
CD45–/– mice were compared. Bone marrow macrophages
from CD45+/+ and CD45–/– mice were harvested and re-
adhered to tissue culture plastic. CD45–/– macrophages
adhered and spread more rapidly than CD45+/+ macro-
phages (68% CD45–/– compared with 37% CD45+/+ spread
after 1 hour). Colocalization of phosphotyrosine-contain-
ing proteins and F-actin at adhesion sites was similar in
CD45–/– and CD45+/+ cells (Fig. 1a–f), and CR3 localized
equivalently in both strains (data not shown). Thus,
CD45–/– macrophages retain the ability to form focal adhe-
sion sites and demonstrate a more rapid rate of adhesion.
Spreading of macrophages on plastic is dependent upon b2
integrins [20]. The ability of the anti-b2 integrin mono-
clonal antibody (5C6) to inhibit adhesion and spreading of
macrophages was tested. Treatment of CD45+/+ (Fig. 2c)
or CD45–/– (data not shown) macrophages with the
monoclonal antibody completely blocked adhesion, con-
firming previous observations [20]. Thus, both CD45–/–
and CD45+/+ macrophages use identical receptors for
adhesion.
Mature CD45–/– and CD45+/+ bone marrow macrophages
were morphologically indistinguishable four hours after b2
integrin-mediated adhesion (Fig. 2a,c), demonstrating that
the presence of CD45 affects the rate but not the final
extent of integrin-mediated adhesion. However, 24 hours
later, the CD45–/– macrophages began to show abnormal
morphology, and after 48 hours were detached from the
plastic (Fig. 2d). This morphological change and loss of
adhesion was not observed with CD45+/+ macrophages
(Fig. 2b), but was consistently observed during in vitro
differentiation of CD45–/– macrophages. To investigate
whether adhesion ligands were secreted, adsorbed or
modified differently on the plates, the ability of CD45–/–
and CD45+/+ macrophages to adhere to plates that had
previously been used to culture either CD45+/+ or CD45–/–
cells was examined. Upon treatment with M-CSF both
CD45–/– and CD45+/+ macrophages were able to re-adhere
to either type of dish (data not shown). Hence, aberrant
adhesion was an inherent property of the CD45–/–
Figure 2
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Adhesion defects in CD45–/– macrophages. CD45+/+ and CD45–/–
macrophages plated for 4 h in M-CSF are shown in (a,c) and after
48 h in (b,d). By 48 h, CD45–/– macrophages had detached from the
non-tissue culture plastic. The inability of macrophages to maintain
adhesion in the absence of M-CSF was consistently observed with
CD45–/–, but never with CD45+/+ cells. (e) Flow cytometric analysis of
macrophages stained for surface expression of CD45, CR3, b1
integrin and c-Fms. Staining with fluorescein-labeled secondary anti-rat
IgG antibody alone (FITC-anti-rat) and secondary anti-rabbit IgG
antibody alone (FITC-anti-rabbit) are also shown as controls. The mean
fluorescence intensity for the total population of cells counted (meanB)
for CD45+/+ and CD45–/– macrophages respectively was: 
FITC-anti-rat 0.39, 0.53; anti-CD45, 9.41, 0.68; anti-CR3, 9.45, 10.5;
anti-b1 integrin, 4.51, 2.95; FITC-anti-rabbit, 0.34, 0.51; anti-c-Fms,
7.58, 7.89. Data shown are representative of two experiments. (f)
Adhesion of CD45+/+ macrophages to non-tissue culture plastic is
inhibited by pre-treatment with anti-integrin amb2 monoclonal antibody
5C6 (anti-CR3). Macrophages were treated with anti-CR3 antibody or
anti-phosphotyrosine (PY20) control before plating on non-tissue
culture plastic. The percentage of cells that adhered and spread was
assessed 1.5 h after plating by counting three separate fields. Data
shown are mean ± S.D. Similar data were obtained with CD45–/–
macrophages.
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macrophages and did not result from differential modifica-
tion of the adhesion surface. 
To examine whether the detachment of CD45–/–
macrophages resulted from aberrant receptor expression,
mature CD45+/+ and CD45–/– macrophages were harvested
24 hours (data not shown) and 48 hours after adhesion and
the expression of adhesion receptors (b2 and b1 integrins),
c-Fms (M-CSF receptor) and CD45 was determined by
flow cytometry (Fig. 2e). As expected, bone marrow
macrophages from the CD45–/– mice did not express
CD45. CD45+/+ and CD45–/– bone marrow macrophages
showed similar expression levels for both the b2 integrin
CR3 and the b1 integrin subunit. The two macrophage
populations also had similar levels of surface c-Fms
expression. Thus, detachment of CD45–/– macrophages
was not the result of deficient maturation and expression
of the b2 integrin CR3, which is the predominant receptor
involved in macrophage adherence to plastic [20], b1
integrins, which may be involved in adhesion of
macrophages to plastic [21], or c-Fms. Despite the equiva-
lent expression of key proteins involved in macrophage
adhesion to plastic in CD45+/+ and CD45–/– macrophages,
we observed adhesion abnormalities in CD45–/– macro-
phages; CD45 itself is therefore an essential regulator of
macrophage adhesion and is required for sustained b2
integrin-mediated adhesion.
Activity of myeloid-specific Src kinases p56/59hck and
p53/56lyn is enhanced in CD45–/– macrophages
Src kinases have been shown to be activated by adhesion
in a number of cell types [3,4]. CD45 is a key regulator of
Src kinases associated with lymphocyte antigen receptors.
Thus, we sought to explore the possibility that CD45 may
affect adhesion via regulation of Src kinase activity. To
examine whether CD45 affects Src kinases during adhe-
sion, CD45+/+ or CD45–/– macrophages were plated on
plastic for the times indicated, and either p53/56lyn or
p56/59hck kinase activity was measured (Fig. 3).
Macrophages were incubated in the presence of M-CSF
because this growth factor increased the extent of
macrophage spreading on plastic. Src kinase activities
were elevated in mature CD45–/– macrophages harvested
after 7 days (data not shown). The kinase activities of
p53/56lyn and p56/59hck were upregulated with increasing
time of adhesion of the CD45–/– and CD45+/+ macrophages
(Fig. 3a). The activity of Src kinases from CD45–/–
macrophages was considerably enhanced at each time
point when compared with CD45+/+ macrophages. Consis-
tent with activation by adhesion, p53/56lyn was localized to
adhesion sites in adherent macrophages for both CD45+/+
(Fig. 1s–u) and CD45–/– macrophages (data not shown). 
To determine whether activation of p53/56lyn and
p56/59hck or their regulation by CD45 was specific to b2
Figure 3
Adhesion activates Src family kinases, with
increased activity in CD45–/– macrophages.
Macrophages were harvested from cultures
in vitro and equal numbers per strain (3 × 106)
were replated. Cells were lysed at the time
points indicated, Src kinases were
immunoprecipitated, and their kinase activities
were determined by [32Pi] incorporation
during in vitro kinase assays. Autoradiograms
of kinase assays are shown, which were
subsequently probed with specific antibodies
to show levels of protein present. Graphs
show the direct quantitation of [32Pi]
incorporated using phosphorimager analysis.
(a) Macrophages were plated on plastic (b2
integrin-dependent adhesion) for the times
indicated with M-CSF (provided in 3% L-cell
supernatant), and the kinase activity of
p53/56lyn and p56/59hck were determined. (b)
Equal numbers of macrophages were either
kept in suspension or adhered to the 110 kDa
RGD-containing fragment of fibronectin (FN)
for 4 h, p53/56lyn was immunoprecipitated
and assayed as described above. Data shown
are representative of three experiments.
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integrins, we examined kinase activation in the absence of
M-CSF during macrophage adhesion to the 110 kDa sub-
unit of fibronectin which contains the Arg–Gly–Glu (RGD
in single letter amino-acid code) integrin-binding motif.
Macrophage adhesion and spreading on the 110 kDa sub-
unit of fibronectin is unaffected by M-CSF and is depen-
dent on b1, b3, and b5 integrins rather than b2 integrins.
A comparison between the macrophages revealed that
p56lyn kinase activity was maximally 5-fold higher in
CD45–/– than in CD45+/+ macrophages (Fig. 3b), and that
p59hck kinase activity was maximally 2-fold higher in
CD45–/– than in CD45+/+ macrophages (data not shown).
Thus, CD45 regulates p53/56lyn and p56/59hck kinase
activity even in the absence of M-CSF.
Src family kinases p56/59hck and p53/56lyn, but not p58c-fgr,
are deregulated in CD45–/– macrophages
CD45–/– macrophages not only have hyperactive p56/59hck
and p53/56lyn kinases, but ultimately de-adhere (Fig. 2d).
To determine whether loss of adhesion results in a change
in kinase activity, three myeloid-specific Src family mem-
bers were examined following spontaneous detachment.
Activities of p53/56lyn and p56/59hck were elevated in
CD45–/– macrophages compared to CD45+/+ macrophages
(Fig. 4a), as assessed by both autophosphorylation, and
phosphorylation of enolase in vitro. Direct quantitation of
kinase activity by phosphorimager analysis, revealed a
3.5–4.6-fold increase in p56/59hck activity (both p56 and
p59 isoforms) and a 4.5–5.1-fold increase in p53/56lyn activ-
ity (both p53 and p56 isoforms) in CD45–/– macrophages
(Fig. 4a). Because the kinase activity remained elevated,
detachment of CD45–/– macrophages was therefore not
due to a loss of Src kinase activity. In contrast to p56/59hck
and p53/56lyn, p58c-fgr did not show increased activity in
CD45–/– macrophages (Fig. 4a). Indeed, p58c-fgr kinase
activity was undetectable in immunoprecipitates from
either CD45–/– or CD45+/+ cells (Fig. 4a). In an identical
assay, p58c-fgr activity could be detected from human
neutrophils, indicating that the failure to detect activity
was not due to the inability of the assay to detect p58c-fgr
activity (data not shown).
To assess whether an equivalent level of each Src family
kinase was expressed by CD45+/+ and CD45–/– macro-
phages, [35S]-methionine/cysteine labeling of mature
macrophages was performed (Fig. 4b, upper panel). Equi-
valent amounts of protein were observed for each kinase.
This demonstrates that the specific activities of p56/59hck
and p53/56lyn were increased in CD45–/– macrophages.
Interestingly, tyrosine phosphorylation of p56/59hck and
p53/56lyn was markedly enhanced in CD45–/– macro-
phages in addition to their elevated kinase activity in
these macrophages (Fig. 4b, lower panel). Comparable
levels of tyrosine phosphorylation of p58c-fgr were not
Figure 4
Deregulation of p56/59hck and p53/56lyn but
not p58c-fgr in CD45–/– macrophages:
hyperactivation correlates with
hyperphosphorylation. (a) p56/59hck, p53/56lyn
and p58c-fgr were immunoprecipitated from
macrophages harvested subsequent to
spontaneous detachment of CD45–/– cells. An
in vitro kinase assay performed with enolase as
an exogenous substrate is shown.
Phosphorylated reduced Ig heavy chains are
just visible as a third band running below
p56hck and coincident with p53lyn. Reprobing
the kinase blot showed equivalent levels of
protein expression via ECL detection (data not
shown). The graph shows the quantitation by
phosphorimager analysis of [32Pi] incorporation
in autophosphorylated p56/59hck and
p53/56lyn or in exogenous enolase. (b) The
same batch of macrophages were labeled with
[35S]-methionine/cysteine for 2 d and
p56/59hck, p53/56lyn and p58c-fgr were
immunoprecipitated consecutively. The [35S]-
labeled samples were run on non-reducing
gels and blotted. Exposure of [35S]-labeled
proteins and detection of phosphotyrosine-
containing proteins using an anti-P-Tyr
antibody were performed on the same
membrane. The data shown are representative
of four experiments. (c) CNBr peptide
fragments of p56lyn. Immuno-precipitated
p53/56lyn from CD45+/+ (3 × 106) and
CD45–/– macrophages (2 × 106) was labeled
by an in vitro kinase reaction (lanes 1,4) and
purified by SDS–PAGE as described
previously. Macrophages, 2.5 × 107, from the
same cell culture were labeled with [32Pi] in
vivo prior to lysis (lanes 2,3). Gel-purified
CNBr digestion fragments of p56lyn are shown.
Identical CNBr fragments were observed in
three separate experiments; labeled fragments
correspond to phosphorylation at the
autophosphorylation site (Auto) or the carboxy-
terminal regulatory site (C).
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detected in either CD45+/+ or CD45–/– macrophages (Fig.
4b, lower panel). 
To determine whether the enhanced tyrosine phosphory-
lation of p56/59hck and p53/56lyn in CD45–/– macrophages
reflected alterations in the sites of phosphorylation in
these molecules, adherent macrophages were labeled in
vivo with [32Pi] for 4–5 hours. Immunoprecipitated p56lyn
and p59hck were subjected to SDS–PAGE, blotted onto
nitrocellulose, and excised from the blots; phosphorylation
sites were determined by cyanogen bromide (CNBr)
digestion of the excised bands (Fig. 4c). Electrophoresis of
CNBr digests of kinases labeled in vitro (Fig. 4c, lanes 1,4)
and digests of kinases labeled in vivo (Fig. 4c, lanes 2,3)
allowed the identification of fragments containing the
autophosphorylation site (Auto), which is known to poten-
tiate kinase activity when phosphorylated, and negative
regulatory carboxyl terminus (C) tyrosine-phosphorylation
sites (Fig. 4c); kinase domains containing the conserved
autophosphorylation sites were more extensively labeled
by in vitro kinase assays. In contrast, the carboxy-terminal
fragments were more extensively labeled during incuba-
tions with [32Pi] in vivo (Fig. 4c). Calculation of the molec-
ular weight of the various CNBr fragments for p56lyn
labeled in vivo yielded a single strongly labeled CNBr
fragment at 5.9 ± 0.7 kDa (Fig. 4c), corresponding to
cleavage at the methionine residue at either position 466
or 463. For p59hck, a predominant carboxy-terminal frag-
ment at 6.6 ± 0.97 kDa was observed, corresponding to
cleavage at the methionine at position 454 (data not
shown). Hyperphosphorylation of the carboxy-terminal
tyrosine residue of Src family kinases in CD45–/– macro-
phages is consistent with the observations made for Src
kinases expressed in T cells [12,22,23]. As the Src family
kinases in macrophages are hyperactive in the absence of
CD45, the extent of the regulatory carboxy-terminal phos-
phorylation does not correlate well with the kinase spe-
cific activity in the whole immunoprecipitated population
of p53/56lyn and p56/59hck. These data suggest that in
addition to its well-described role in activating Src family
kinases, CD45 is also important in decreasing Src family
kinase activity possibly by regulating phosphorylation at
the tyrosine residue in the kinase domain. A similar obser-
vation has recently been made by D’Oro et al. [24].
CD45 inactivation of Src kinases by dephosphorylation of
the tyrosine phosphorylation site within the kinase domain
To determine whether CD45 could regulate p56/59hck or
p53/56lyn activity via dephosphorylation, the Src kinases
were immunoprecipitated from either CD45+/+ or CD45–/–
macrophages and incubated in vitro with recombinant
CD45 phosphatase domain (comprising amino acids
566–1268, bacterially expressed and purified by HPLC
using sizing chromatography). Recombinant CD45 de-
phosphorylated each kinase and concomitantly decreased
kinase activity indicating that CD45 is capable of directly
regulating both p56/59hck and p53/56lyn by dephosphoryla-
tion (data not shown). To support these data and to
examine kinase regulation by CD45 within adherent cells
in vivo, p56hck and either wild-type CD45 or a mutant
form of CD45 rendered catalytically inactive by mutation
of the active site cysteines to serines, creating CCSS-
CD45, were cotransfected into HeLa cells (Fig. 5a). When
compared to catalytically inactive CD45 (lane 2), coex-
pression of wild-type CD45 resulted in decreased phos-
phorylation and kinase activity of p56hck to 13% of the
activity obtained upon cotransfection with the mutant
after normalization of protein levels (Fig. 5a). 
For direct comparison with a lymphocyte-specific Src
kinase, p56lck was cotransfected with either wild-type or
mutant CD45 (Fig. 5a). In contrast to p56hck, p56lck activ-
ity was unaltered when expressed with either catalytically
active or inactive CD45, after normalization for protein
levels. Both the kinase and the phosphatase were
expressed at the plasma membrane in transfected HeLa
cells (data not shown). Therefore, although in lympho-
cytes CD45 is known to regulate p56lck by dephosphoryla-
tion of the carboxy-terminal negative regulatory site,
CD45 does not efficiently regulate p56lck in HeLa cells.
This finding suggests that lymphoid-specific factors might
be required for the colocalization and/or regulation of
p56lck by CD45. However, these experiments demonstrate
that CD45 can directly and specifically inactivate
p56/59hck in adherent cells, suggesting that individual Src
family members expressed in the same cell can be regu-
lated differently.
When coexpressed with CD45, the concomitant decrease
in p56hck tyrosine phosphorylation and kinase activity sug-
gests that CD45 can dephosphorylate the tyrosine within
the kinase domain, a site known to potentiate kinase
activity when phosphorylated. To examine the mecha-
nism by which CD45 regulates p56hck activity, CD45 or
CCSS-CD45 were coexpressed in HeLa cells with a
mutant form of p56hck bearing a mutation of the carboxy-
terminal negative regulatory tyrosine phosphorylation site
to phenylalanine (p56hckY501F; Fig. 5b). Coexpression of
catalytically active CD45 resulted in decreased tyrosine
phosphorylation of p56hckY501F when compared to expres-
sion with catalytically inactive CD45 (approximately a
three-fold decrease by densitometic analysis). CNBr
digestion of p56hckY501F from HeLa cells labeled with
[32Pi] demonstrates that the tyrosine within the kinase
domain is the major site of phosphorylation (Fig. 5c).
Thus, CD45 is capable of dephosphorylating the tyrosine
phosphorylation site within the kinase domain. Similar
results were obtained when either catalytically active or
inactive CD45 was coexpressed with p53lyn containing a
phenylalanine to lysine mutation at the negative regula-
tory site (data not shown). Together, these data suggest
that the increased kinase activity in CD45–/– macrophages
414 Current Biology, Vol 7 No 6
results from the lack of CD45-mediated dephosphory-
lation of the potentiating phosphorylation site within the
kinase domain of p56/59hck and p53/56lyn.
Discussion
Adhesion sites are critical for the initiation of many signal-
ing cascades [2,3]. The observation that adhesion is
required for growth of untransformed cells in vitro has now
been supplemented with a large amount of molecular
detail. A critical issue in the initiation of signal transduc-
tion pathways is the targeting of low abundance molecules
to specific locations in the cell where they can accumulate
to sufficient concentration to initiate an enzymatic
cascade. Both cell–cell and cell–substrate adhesion sites-
bring together a range of cytoskeletal and docking mole-
cules which allow assembly of these cascades [3,4]. Thus,
regulation of the molecular architecture of these adhesions
is a critical step in the regulation of proliferation, gene
induction, and other aspects of cell function. Not only do
the adhesion sites allow for the assembly of signaling cas-
cades, but modification of these sites by localized
enzymes can provide an adaptable platform to which dif-
ferent molecules can be targeted and on which different
cascades can assemble. In this context, targeting tyrosine
phosphatases to adhesion sites [5,25] is expected to be
extremely important for normal cell function. 
Our studies demonstrate distinct adhesion abnormalities in
CD45–/– macrophages; these abnormalities are likely to
have profound repercussions on normal macrophage devel-
opment and activation, because adhesion is required for
macrophages to mature and respond to environmental stim-
uli. Indeed, we obtain consistently fewer mature bone
marrow-derived macrophages from CD45–/– mice than from
CD45+/+ mice when differentiated in vitro (data not shown).
CD45–/– bone marrow macrophages differentiated in vitro
demonstrate exaggerated adhesion and spreading early
after receiving a stimulus to adhere to plastic but fail to
sustain b2 integrin-mediated adhesion. Epithelial cell–cell
adherens junctions at sites of homophilic cadherin interac-
tions are not maintained following transformation with v-src
or inhibition of PTPase activity [7,26,27], suggesting that
transmembrane PTPases have a central role in the main-
tenance of intercellular adhesions. CD45 clearly plays a
similar role in the regulation of b2 integrin-mediated adhe-
sion in macrophages. The aberrant adhesion in CD45–/–
macrophages is probably related to the increased activity of
p56/59hck and p53/56lyn, two Src kinases that are highly
expressed in myeloid cells. Integrin-mediated phagocytosis
and adhesion-dependent differentiation and activation of
macrophages have been linked previously to the activation
of Src family members [28–30]. Deregulation of these
kinases in the absence of CD45 could affect normal feed-
back mechanisms that are required to maintain adhesion.
Figure 5
CD45 directly regulates p56hck but not p56lck kinase activity and
p56hckY501F and kinase domain phosphorylation in adherent cells in
vivo. Transient transfection assays were performed in recombinant T7
vaccinia-infected HeLa cells. (a) Cells were transfected with either
catalytically inactive CD45 (CCSS-CD45) or wild-type CD45 together
with either p56hck or p56lck as indicated. The control sample
corresponds to untransfected HeLa cells. After 14 h, cells were lysed,
CD45 and Src kinases were immunoprecipitated, kinase activity was
assayed in vitro, and samples were electrophoresed through reducing
SDS–PAGE gels. The upper panel shows the expression levels of
CD45 proteins as detected by ECL, the middle panel shows
autoradiographs of in vitro kinase assays of Src kinases, and the lower
panel shows the ECL detection of p56hck and p56lck on same blot.
Kinase activity was quantitated by phosphorimager analysis. (b) HeLa
cells were transfected with CCSS-CD45 or wild-type CD45 with
p56hckY501F which contains a mutation of the carboxy-terminal tyrosine
residue to phenylalanine leaving the conserved kinase domain
tyrosines intact. After 16 h, cells were lysed, CD45 and Src kinases
were immunoprecipitated, electrophoresed through non-reducing
SDS–PAGE gels, and protein expression levels and phosphotyrosine
detected by ECL as indicated. (c) HeLa cells were cotransfected with
CCSS-CD45 and p56hckY501F. After 16 h, cells were labeled with [32Pi]
for 4 h, and p56hckY501F isolated by immunoprecipitation followed by
SDS–PAGE. CNBr fragments were separated on a 24%
tricine–polyacrylamide gel. In addition, p56hck was isolated by
immunoprecipitation from bone marrow-derived macrophages (BM;
2 × 106), labeled in an in vitro kinase reaction, subjected to CNBr
digestion and resolved on a 24% tricine–polyacrylamide gel.
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The role of CD45 in regulating p56/59hck and p53/56lyn
activity in macrophages is distinct from its role in regulating
the activation of Src family kinases in lymphocyte antigen
receptor signaling. In several lymphoid cell lines and T-cell
clones, expression of CD45 is required in antigen receptor-
induced activation to dephosphorylate the negative regula-
tory carboxy-terminal tyrosine phosphorylation sites of
p56lck or p57fyn, resulting in an increase in the kinase activ-
ity of these proteins [12–14]. The increase in carboxy-ter-
minal phosphorylation of these kinases in CD45–/–
macrophages indicates that CD45 also functions to dephos-
phorylate this site in macrophage-specific Src family
kinases. But, in contrast to antigen activation in lympho-
cytes, the predominant effect of CD45 in macrophages is to
limit p56/59hck and p53/56lyn activation probably by dephos-
phorylating the autocatalytic site during integrin-mediated
adhesion. CD45 has been shown to inhibit p56lck activity
when these proteins are coclustered in T cells using anti-
bodies against CD4 and CD45 [31], suggesting that CD45
has two quite different roles in regulating Src family kinases
depending on the stimulus for kinase activation.
The differences in CD45 regulation of Src family kinases
can be reconciled by proposing that the kinases are acti-
vated by different mechanisms during adhesion and
antigen activation. Specifically, Src kinases may be acti-
vated during adhesion by binding to high affinity SH2-
binding and/or SH3-binding sites in proteins localized at
focal adhesion sites, thus explaining why the macrophage
Src family kinases are active even if phosphorylated at the
carboxy-terminal regulatory site. In contrast, in antigen-
induced activation, initiation of signaling requires phos-
phorylation by Src kinases of immunoreceptor
tyrosine-based activation motifs (ITAMS) located in the
cytoplasmic domain of antigen receptors [32]. Importantly,
and in contrast to adhesion, Src family kinases are thought
to be the first kinases in the enzymatic cascade following
antigen activation. Thus, in this circumstance, activation
requires dephosphorylation of the negative regulatory site
by CD45, which notably occurs before antigen recognition
[33]. By contrast, in adherent macrophages, CD45 is not
required for activation of Src kinases, which instead may be
driven by allosteric interactions at focal adhesion sites, but
negatively regulates kinase activity by dephosphorylating
Src kinases after adhesion-induced activation. This role for
CD45 would not be detected in antigen-induced activa-
tion, because kinase activity is not detectable in the
absence of CD45-mediated dephosphorylation of the nega-
tive regulatory site. Examples of CD45–/– T-cell and B-cell
lines with increased p56lck and p59fyn or p53/56lyn kinase
activity, respectively, have been reported [23,34]. Although
the adhesive properties of these cells were not described, it
is possible that the common link between these cell lines
and CD45–/– macrophages is the failure to appropriately
regulate the adhesion-induced activation of Src family
kinases. Clearly, the extent of carboxy-terminal tyrosine
phosphorylation does not correlate well with kinase activity
[24]. A possible explanation is that the active kinase mole-
cules are a minority of the total p56/59hck or p53/56lyn pool,
and that these active molecules are phosphorylated on
their kinase domains.
Src kinases can be activated at adhesion sites by binding to
tyrosine-phosphorylated focal adhesion kinase (pp125FAK)
[35]. Indeed, pp125FAK localization to sites of integrin-
mediated adhesion seems to be a very early step in the
assembly of a focal adhesion [3,4]. However, there must be
other means of locating and activating Src kinases at adhe-
sion sites, because no role for pp125FAK has been convinc-
ingly demonstrated in leukocyte activation. Indeed, like
human monocytes [21], mouse bone marrow macrophages
contain no immunologically detectable pp125FAK (data not
shown). Other members of the pp125FAK family [36] might
contribute to Src family kinase activation in leukocytes.
Transmembrane tyrosine phosphatases PTPase m, PTPase
k, LAR (leukocyte common antigen-related), and Droso-
phila DPTPase 10D are likely to be important in regulating
cell–cell adhesions in epithelia [5,25]. These phosphatases
can participate in adhesion directly, through their extracel-
lular domains, and/or can regulate the function of other ad-
hesion molecules, such as cadherins, by their phosphatase
activity [3,4,37]. Although the importance of the phospho-
rylations of intercellular adhesion molecules is not certain,
studies using phosphatase inhibitors suggest that b catenin
phosphorylation, and/or phosphorylation of other proteins
at adhesion sites, may loosen adherens junctions [7,8].
Hyperphosphorylation of integrins also can inhibit cell
adhesion [38]. There are obvious parallels between the role
of tyrosine phosphatases in regulating cadherin contacts in
epithelial cells and our data reported here regarding the role
of CD45 in integrin-mediated adhesion. CD45, like LAR or
PTPase m, may ultimately regulate the phosphorylation of
cytoskeleton-associated molecules that are important in
the formation and/or maintenance of the adhesion site. For
the epithelial transmembrane phosphatases, the relevant
kinases that are regulated in this manner are unknown. In
macrophages, CD45 regulates adhesion sites by reducing
the activity of the Src kinases p56/59hck and p53/56lyn. The
key role of myeloid-specific Src kinases in regulating inte-
grin-dependent adhesion and activation in neutrophils has
recently been demonstrated by cells that fail to express
p56/59hck and p58c-fgr being defective in adhesion depen-
dent activation [39]. The regulation and modulation of
adhesion-activated Src family kinases may be a fundamen-
tal role for transmembrane tyrosine phosphatases.
Materials and methods
Mice
CD45–/– mice, generated by targeted disruption of exon 6 [11], and
their CD45-expressing littermates were maintained in a specific
pathogen-free facility. CD45 genotypes of individual mice were deter-
mined by PCR analysis of ear punch DNA to detect the presence of
the neomycin cassette used in the targeted disruption. Only homozy-
gous CD45+/+ and CD45–/– littermates were used in experiments.
CD45–/– mice had been backcrossed to B6 mice for at least six gener-
ations. Mice were from 6 to 12 weeks of age, and were sex- and age-
matched (± 2 weeks) within experiments.
Culture of bone marrow macrophages
Bone marrow cells were harvested as previously described [40]. Resi-
dent adherent cells were removed by plating the cells on tissue culture
plastic petri dishes for 2–3 h in bone marrow macrophage-medium
(BMM-medium) consisting of high glucose Dulbecco’s modified
Eagle’s medium (DMEM; Gibco-BRL), with 10% fetal bovine serum
(FBS; HyClone Labs), 20 mM HEPES with 2% L929 cell-conditioned
supernatant (L-cell supernatant) as a source of M-CSF. The non-adher-
ent population, including the promonocytes were harvested, counted
and replated on non-tissue culture treated plastic (Valmark ‘ultradish’,
Midwest Scientific) at 5 × 106 to 1 × 107 cells per dish in 12–15 ml
BMM-medium with 15% L-cell supernatant as previously described
[40]. Bone marrow cells from CD45+/+ and CD45–/– mice were plated
at the same density. Cultures were fed on day 4 with fresh medium
containing 5–7.5% L-cell supernatant. Mature bone marrow macro-
phages were harvested from day 6 to day 15 in PBS containing 10 mM
EDTA and used as indicated. During replating experiments, the con-
centration of L-cell supernatant in the bone marrow macrophage
medium varied as indicated. To maintain cultures beyond day 8, bone
marrow macrophages were fed at regular intervals with fresh medium
containing 2–5% L-cell supernatant. Mature macrophages used in
experiments had at least a 24 h rest from L-cell M-CSF. To examine
whether macrophage adhesion was dependent upon b2 integrins,
either CD45+/+ or CD45–/– macrophages were treated with super-
natant from either rat anti-mouse CR3, 5C6 (anti-amb2 integrin) or
isotype-matched control at 4°C for 1 h. Macrophages were plated with
fresh hybridoma supernatant on non-tissue culture plastic for 1.5 h at
37°C. The percentage of attached cells was determined by counting
cells that were adherent and spread in three separate fields.
Reagents and antibodies
Rat monoclonal antibodies against CD45 (I3/2), CR3 (M1/70) and b1
integrin chain (MB1.2) and a mouse monoclonal antibody against
C57BL/6 MHC class I (28-14-8) were used as hybridoma supernatants
for flow cytometric staining, and immunofluorescent localization. Anti-
phosphotyrosine mouse monoclonal antibody (4G10, UBI), and affinity
purified anti-p56/59hck, anti-p53/56lyn, anti-p58c-fgr and anti-p56lck rabbit
sera (Santa Cruz Biotechnology), and rat anti-CD45 (Pharmingen) or a
rabbit antibody raised against the CD45 cytoplasmic domain were used
in immunoprecipitations and, with the exception of the rat anti-CD45
monoclonal antibody, all antibodies were also used to probe western
blots. Horseradish peroxidase-conjugated goat anti-mouse IgG2b (Cal-
tag Labs)), or goat anti-rabbit IgG (Pierce) were used on western blots
with either ECL substrate (Amersham Life Science) or SuperSignal CL-
HP substrate (Pierce). Immunoprecipitations were performed using
affinity gels coupled to affinity-purified goat antibody to rat IgG (Cap-
pel/Organon Teknika Corp.), or to protein-A (Pharmacia). Affinity-purified
and other species of pre-adsorbed FITC- or CY3-coupled secondary
antibodies were purchased for immunostaining. FITC–sheep (F(ab′)2
fragment) anti-mouse IgG (Sigma), CY3–donkey anti-rat, CY3–donkey
anti-rabbit, CY3–donkey anti-mouse (Jackson Immuno-Research Lab-
oratories) and rhodamine- or FITC-phalloidin (Molecular Probes). 
Fluorescent flow cytometric analysis
Fluorescent flow cytometry was performed using 5% goat serum with
human IgG (500 mg ml–1) to block macrophage Fcg receptors. Primary
rat monoclonal antibodies against CD45, CR3 and b1 integrin (used
as hybridoma supernatants), and rabbit anti-c-Fms extracellular domain
(UBI), were detected using FITC-conjugated F(ab′)2 anti-rat IgG or
anti-rabbit IgG respectively (Sigma).
Immunofluorescent localization of bone marrow proteins
In vitro matured macrophages were allowed to adhere (3–24 hr) to
glass coverslips in 5% L-cell supernatant, then fixed with 2%
paraformaldehyde (10 min). Following 0.5% Triton-X 100 extraction for
2 min, cells were stained with primary and secondary antibodies with
appropriate blocking according to standard protocols. For immunofluo-
rescent colocalization, the adherent surface images were obtained
using a BioRad MRC 600 confocal scanning microscope and Aldus
Photostyler version 2.0 software or epifluorescence microscopy using
a Zeiss Axioscope and GIPSSPC image processing system (Georgia
Instruments). 
Immunoprecipitation, SDS–PAGE and immunoblots
Bone marrow macrophages, 3 × 106 cells per point, were lysed in ice
cold Tris-buffered saline (150 mM NaCl, 50 mM Tris-HCl pH 7.5) con-
taining 1% Triton X-100 (Pierce), 1% deoxycholate, 1 mM EDTA (lysis
buffer), with 10 mg ml–1 leupeptin, 10 mg ml–1 aprotinin, 1 mM NaF,
200 mM pervanadate and 2 mM diisopropyl-fluorophosphate (all chemi-
cals from Sigma). After 30 min rotation at 4°C, nuclei and debris were
removed by centrifugation (10 000 × g for 10 min), and supernatants
collected. All incubations for immunoprecipitations were performed for
1 h while rotating samples at 4°C. Immunoprecipitates were washed
three times in lysis buffer with 2.5 mg ml–1 leupeptin and aprotinin,
1 mM NaF, and 200 mM pervanadate. SDS–PAGE and immunoblotting
with ECL detection performed following manufacturers’ protocols.
Kinase assays
Kinase activity of p56/59hck, p53/56lyn, p58c-fgr or p56lck immunopre-
cipitates was determined by addition of 5–10 mCi g-[32P]-ATP
(4500 Ci mM–1, ICN Biomedicals) in 40 mM HEPES pH 7.4, 10 mM
MgCl2, 3 mM MnCl2, 200 mM pervanadate with 10% glycerol, 1 mM
DTT, and 5 mM unlabeled ATP, with or without 10 mg of acid-dena-
tured enolase as indicated. Samples were vortexed and incubated for
20 min at room temperature. Reactions were stopped by adding an
equivalent volume of 2 × Laemmli SDS–PAGE sample buffer.
In vivo [32Pi] labeling and CNBr digestion
Macrophages were harvested. washed in phosphate-free DMEM, then
2–4 × 107 cells were replated in 10 ml phosphate-free 5% dialyzed
FBS/DMEM with 0.75 mCi ml–1 [32Pi] (400–800 mCi ml–1, HCl-free,
ICN Biomedicals) and allowed to adhere for 4–5 h. Adherent cultures
of HeLa cells, in 10 cm2 dishes, were washed twice with phosphate-
free DMEM and incubated in 3.75 ml phosphate-free 5% dialyzed
FBS/DMEM with 1 mCi ml–1 [32Pi] for 4–5 h. Macrophages and HeLa
cells were lysed as described previously and p53/56lyn and p56/59hck
immunoprecipitated. SDS–PAGE gels were blotted onto 0.22 mm
nitrocellulose (MSI), exposed to film to identify the kinase bands, and
the p56 and p59 bands for p53/56lyn and p56/59hck were removed
respectively for CNBr digestion (4–5 h at room temperature,
100 mg ml–1 CNBr in 70% formic acid). Digests were lyophilized then
prepared for loading on 24% tricine gels using an adaptation of the
discontinuous procedure of Schagger and von Jagow (Sigma).
Vaccinia/HeLa transient transfection system
HeLa cells were infected with recombinant vaccinia virus expressing
the T7 RNA polymerase [41] with a multiplicity of infection of 10 for
30 min, immediately prior to transfections with human p56hck or
p56hckY501F, murine p53lyn (obtained from Daniel Link), murine
p53lynY508F (obtained from Chris Goodnow and Richard Cornall) or
p56lck and CD45 or catalytically inactive CCSS-CD45 (made using
site-directed mutagenesis to convert Cys840 and Cys1155 to serine
residues). Ratios of plasmids to be used in cotransfections, to obtain
similar levels of expression of both proteins, were determined by titra-
tion. Vaccinia-infected HeLa cells were transfected with 5 mg total
DNA using lipofectace (Gibco BRL), and cells were left for 14–16h
prior to lysis. CD45 constructs were expressed as transmembrane pro-
teins as determined via flow cytometry analysis of HeLa cells prior to
lysis (data not shown).
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